L. Hegemann
Impact in
- Dermatology top 5%
- Acne and Rosacea Treatments and Effects
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
Papers in ⓘ
-
- Retinoids in leukemia and cellular processes 3
-
- Phytochemistry and Bioactive Compounds 3
- Co-authors
- Lucio A.A. Van Rooijen (4 shared papers)G. Mahrle (6 shared papers)Guy Webster (3 shared papers)Jouni Uitto (1 shared paper)Bernard Schmidt (3 shared papers)Bernd Bonnekoh (4 shared papers)J. Traber (2 shared papers)B. Partsch (1 shared paper)
- Journals
- Archives of Dermatological Research (4 papers)British Journal of Dermatology (3 papers)Journal of Dermatological Science (2 papers)Journal of Investigative Dermatology (2 papers)PubMed (3 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
L. Hegemann
15 papers receiving 333 citations
Peers
Comparison fields: 5 of 80
- Dermatology 124
- Pharmaceutical Science 36
- Pharmacology 27
- Immunology 63
- Toxicology 10
Countries citing papers authored by L. Hegemann
This map shows the geographic impact of L. Hegemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Hegemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Hegemann more than expected).
Fields of papers citing papers by L. Hegemann
This network shows the impact of papers produced by L. Hegemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Hegemann. The network helps show where L. Hegemann may publish in the future.
Co-authors
The 15 scholars most cited alongside L. Hegemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. | 1994 | 94 |
| 2 | 1993 | 53 | |
| 3 | 1995 | 41 | |
| 4 | 1994 | 40 | |
| 5 | 1991 | 28 | |
| 6 | 1992 | 19 | |
| 7 | 1991 | 14 | |
| 8 | 1992 | 13 | |
| 9 | Anthralin: how does it act and are there more favourable derivatives? | 1994 | 12 |
| 10 | 1994 | 10 | |
| 11 | 1992 | 8 | |
| 12 | 1992 | 5 | |
| 13 | 2006 | 4 | |
| 14 | Selective calmodulin antagonists fail to inhibit phorbol ester-induced superoxide anion release from human neutrophils: effects of antifungal azole derivatives. | 1996 | 3 |
| 15 | 1996 | 2 |
About L. Hegemann
L. Hegemann is a scholar working on Molecular Biology, Biomaterials, Immunology, Dermatology and Pharmacology, having authored 15 papers that have together received 346 indexed citations. Recurring topics across this work include Vitamin C and Antioxidants Research (3 papers), Retinoids in leukemia and cellular processes (3 papers), Phytochemistry and Bioactive Compounds (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Acne and Rosacea Treatments and Effects (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). The work is most often cited by research in Dermatology (124 citations), Pharmaceutical Science (36 citations), Pharmacology (27 citations), Immunology (63 citations) and Toxicology (10 citations). L. Hegemann has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Lucio A.A. Van Rooijen, G. Mahrle, Guy Webster, Jouni Uitto, Bernard Schmidt, Bernd Bonnekoh, J. Traber, B. Partsch, Klaus Wolff and R. Müller‐Peddinghaus. Their work appears in journals such as Archives of Dermatological Research, British Journal of Dermatology, Journal of Dermatological Science, Journal of Investigative Dermatology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.